超声膀胱壁厚度与前列腺钙化同UPOINT评分的相关性
该回顾性研究分析了1294例慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)患者,评估超声测定的膀胱壁厚度(BWT)和前列腺钙化与UPOINT分类系统的相关性。结果显示BWT≥3.3与所有测量指标显著相关,而钙化仅与NIH-CPSI总分和BWT相关。结论认为BWT测量可作为依据UPOINT评分诊断CP/CPPS的客观方法。
要点
- BWT≥3.3与UPOINT各领域及症状评分均显著相关。
- 前列腺钙化仅与NIH-CPSI总分和BWT相关,与年龄和UPOINT总分无关。
- 超声BWT测量可作为CP/CPPS的客观诊断辅助工具。
核心结论
- BWT测量可作为依据UPOINT评分系统诊断CP/CPPS的便捷客观方法。
研究设计与样本
- 回顾性分析2008年1月至2017年12月单中心泌尿外科诊所1294例确诊慢性前列腺炎患者的数据。
- 纳入21-65岁且完成所有问卷的患者,排除问卷不依从、急/慢性细菌性前列腺炎、泌尿生殖系肿瘤史、近期前列腺手术及影响膀胱的神经系统疾病。
主要发现
- 患者中位年龄37岁(IQR=13,范围21-65),中位UPOINT子域为2(IQR=1,范围0-5)。
- BWT中位值为3(IQR=1,范围2-6,7),NIH-CPSI中位值为4(IQR=6,范围1-23),IIEF中位值为25(IQR=10,范围1-30)。
- 前列腺钙化与NIH-CPSI总分和BWT显著相关,与年龄和UPOINT总分关系不显著。
- BWT≥3.3与所有描述指标均显示强且统计学显著的相关性。
关键数值与推荐
- BWT≥3.3与所有测量指标(包括NIH-CPSI、UPOINT等)显著相关。
- 前列腺钙化与NIH-CPSI总分和BWT显著相关,与年龄和UPOINT总分无关。
临床怎么用
- 临床可考虑使用超声测量BWT作为CP/CPPS的客观辅助诊断工具,尤其当BWT≥3.3时提示与症状评分相关。
局限性
- 回顾性研究设计,可能存在选择偏倚。
- 单中心数据,结果外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate ultrasonically determined bladder wall thickness (BWT) and prostatic calcification presence, in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), and to correlate the findings with patient characteristics and the urinary, psychosocial dysfunction, organ specific, infection and neurological/systemic symptoms, and tenderness (UPOINT) classification system. MATERIAL AND METHODS: Between January 2008 and December 2017, data of 1294 patients diagnosed with chronic prostatitis, in a single urology clinic, meeting a number of selective inclusion/exclusion criteria, were retrospectively analyzed. Patients, compliant to fill out all requested questionnaires, between the ages of 21-65 years were included to the study. Exclusion criteria were noncompliance of filling out required questionnaires, acute and/or chronic bacterial prostatitis, history of genitourinary cancer, history of recent prostate surgery, and diagnosis of neurological diseases affecting the bladder. RESULTS: The median patient age and UPOINT subdomain was determined as 37 (IQR = 13, range 21-65) and 2 (IQR = 1, range 0-5), respectively. Median values for BWT, National Institute of Health-Chronic Prostatitis Symptom Index (NIH-CPSI), and International Index of Erectile Function were 3 (IQR = 1, range 2-6, 7), 4 (IQR = 6, range 1-23), and 25 (IQR = 10, range 1-30), respectively. The presence of calcification demonstrated a significant association with total NIH-CPSI score and BWT, whereas its relation with age and total UPOINT score was insignificant. However in contrast to calcification status, BWT ≥3.3 showed a strong and statistically significant relation to all the described measurements. CONCLUSION: Measurement of BWT can be used as an accessible and objective method for the diagnose of CP/CPPS according to UPOINT scoring system.
引用
- Arda E, Cakiroglu B, Akdeniz E, et al. Correlation of Ultrasonically Determined Bladder Wall Thickness and Prostatic Calcification With the Urinary, Psychosocial Dysfunction, Organ Specific, Infection and Neurological/Systemic Symptoms, and Tenderness Scoring System. Urology. 2018. PMID: 30528713. doi:10.1016/j.urology.2018.11.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。